NeuroOne (NMTC) Q3 2026 Earnings Call Transcript
Product revenue grew 16% YoY as new orders hit $2.7M, outpacing manufacturing capacity.
Welcome to the third quarter fiscal 2026 financial results conference call for NeuroOne Medical Technologies Corporation. Co-CEO Dave Rosa, CFO Chris Volker, and CBO Dave Wambecke will be present to discuss the company's performance. The call will include forward-looking statements and potential risks and uncertainties that may cause actual results to differ from those expressed. Please join us as the co-CEOs, CFO, and CBO present an overview of the company's financial performance and discuss future growth opportunities.
Written by urgent.news from Yahoo Finance's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- NeuroOne (NMTC) Q3 2026 Earnings Call Transcript finance.yahoo.com
- NeuroOne (NMTC) Q3 2026 Earnings Call Transcript nasdaq.com
